Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

BeyondSpring Inc (BYSI)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow BeyondSpring's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
1.830 +0.030    +1.67%
15:24:10 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 76,770
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.800 - 1.968
BeyondSpring 1.830 +0.030 +1.67%

BeyondSpring Inc Company Profile

 
Get an in-depth profile of BeyondSpring Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

73

Equity Type

ORD

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company’s lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

Contact Information

Address 28 Liberty Street 39th Floor
New York, 10005
United States
Phone 646 305 6387
Fax 646 882 4228
Web beyondspringpharma.com

Top Executives

Name Age Since Title
Lan Huang 52 2014 Co-Founder, Chairman & CEO
Matthew Kirkby 54 2016 Independent Director
David S. Ettinger - - Member of Scientific Advisors & Principal Investigators Board
Yan Sun - - Member of Scientific Advisors & Principal Investigators Board
Yuankai Shi - - Member of Scientific Advisors & Principal Investigators Board
Jiangwen Majeti 55 2022 Director
Patrick Fabbio 55 2018 Independent Director
Jeffrey Crawford - - Member of Scientific Advisors & Principal Investigators Board
Brendan P. Delaney 47 2021 Independent Director
Douglas W. Blayney 73 - Member of Scientific Advisors & Principal Investigators Board
Sihai Xu 51 2022 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BYSI Comments

Write your thoughts about BeyondSpring Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mr Steel
Mr Steel Nov 30, 2021 3:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$70s incoming
Reply
5 2
Report
AJ Phillips
AJ Phillips Aug 09, 2021 5:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I was right. Yay me.
Reply
0 0
Report
AJ Phillips
AJ Phillips Aug 09, 2021 5:25AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
here we go. ride the wave, in with 1000 shares at 9.56
Reply
1 0
Report
Andrew Wark
Andrew Wark Aug 04, 2021 11:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Another pump n dump. Everyones chasing the next med stock in hopes of ending the covidnoia It's not going to happen. Covid is a tool the corrupt governments have now to control the people and they'll never give it up. It's how they'll rig the 2022 mid term as well.
Reply
4 8
Report
Show previous replies (3)
Scott McCoy
Scott McCoy Aug 04, 2021 11:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ukraine??
Reply
0 0
Report
Scott McCoy
Scott McCoy Aug 04, 2021 11:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Uzbekistan??
Reply
0 0
Report
Scott McCoy
Scott McCoy Aug 04, 2021 11:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Nison Kay Uganda??
Reply
0 0
Report
Scott McCoy
Scott McCoy Aug 04, 2021 11:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Uruguay??
Reply
0 0
Report
jason xx
jason xx Aug 04, 2021 11:40AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This has nothing to do with covid you paranoid conspirim o r. on
Reply
0 0
Report
Federico Solow
fedexsolow Aug 04, 2021 10:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what's going on  is it stuck on 24.59?
Reply
0 1
Report
Anthony Trader
ATTrader Aug 04, 2021 10:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Halted due to volatility. Resumed trading though and climbing. =)
Reply
0 0
Report
Anthony Trader
ATTrader Aug 04, 2021 10:15AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
HC Wainwright & Co upgrades BYSI on trial results news and sets PT of $100
Reply
1 0
Report
Nathan Penk
Nathan Penk Aug 04, 2021 8:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
"shorty get down, good lord" music quotes that make a lot of sense rn
Reply
0 0
Report
Batuhan Babür
Batuhan Babür Aug 04, 2021 8:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
:) who buy from here lol stupid pre market
Reply
0 0
Report
AJ Phillips
AJ Phillips Dec 12, 2020 4:04AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Real PT of $25EOY and PT of $200 if an acquisition comes in. It's at the bottom right now at 10.60. BUY
Reply
4 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email